Trading window closed from July 1 ahead of Q1 results

AARTIPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.1%1-day move

₹707.00

prior close

₹712.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.3+0.3+0.3+0.3-1.1-4.1-3.8-0.7-0.6-0.6+0.8-4.5——

Up moveDown movePending

AI summary

Aarti Pharmalabs has closed its trading window from Wednesday, July 1, 2026 until 48 hours after the declaration of financial results for the quarter ending June 30, 2026. This is a routine insider trading compliance measure under SEBI (Prohibition of Insider Trading) Regulations, 2015. All designated persons and connected persons are barred from dealing in company securities during this period. The board meeting date to approve the Q1 results will be informed later.

Likely market impact

Routine compliance filing; signals upcoming Q1 FY27 results. No direct impact on retail shareholders, but insiders cannot trade until results are announced.